VOC analysis

DEVICE5 trials

Sponsors

Hopital Foch

Conditions

AsthmaChronic Obstructive Pulmonary Disease ExacerbationChronic Obstructive Pulmonary Disease SevereLung Cancer, Non-small Cell

Unknown Phase

Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection

Hopital FochLung Cancer, Non-small Cell

Start: 2018-09-20End: 2021-09-30Target: 50Updated: 2020-12-19

Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air

Hopital FochAsthma

Start: 2018-12-04End: 2022-12-31Target: 50Updated: 2021-02-16

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response

TerminatedNCT03988192

Hopital FochLung Cancer, Non-small Cell

Start: 2018-08-28End: 2021-05-26Updated: 2022-01-27

Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)

Hopital FochChronic Obstructive Pulmonary Disease Exacerbation

Start: 2021-03-17End: 2022-11-30Target: 40Updated: 2021-03-30

Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)

Hopital FochChronic Obstructive Pulmonary Disease Severe

Start: 2021-10-13End: 2023-06-13Target: 40Updated: 2022-01-28